Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
79
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Alternative treatment strategies to sorafenib in patients with advanced hepatocellular carcinoma: a meta-analysis of randomized Phase III trials

Hui WangDepartment of Radiation Oncology, Yancheng First People’s Hospital, Yancheng, Jiangsu 224005, China, [email protected]Correspondence[email protected]
,
Hefang WangDepartment of Radiation Oncology, Yancheng First People’s Hospital, Yancheng, Jiangsu 224005, China, [email protected]
,
Zhichong YuDepartment of Radiation Oncology, Yancheng First People’s Hospital, Yancheng, Jiangsu 224005, China, [email protected]
&
Honghao LiuDepartment of Radiation Oncology, Yancheng First People’s Hospital, Yancheng, Jiangsu 224005, China, [email protected]
Pages 5195-5201 | Published online: 27 Aug 2018

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Shuo Yang, Minggang Wang, Liang Yang, Yan Li, Yingbo Ma, Xueqiang Peng, Xinyu Li, Bowen Li, Hongyuan Jin & Hangyu Li. (2020) MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib. OncoTargets and Therapy 13, pages 3557-3570.
Read now

Articles from other publishers (5)

Congfang Guo, Xiang Guo, Yudong Rong, Yirui Guo & Li Zhang. (2021) Gene Expression Characteristics of Liver Tissue Reveal the Underlying Pathogenesis of Hepatocellular Carcinoma. BioMed Research International 2021, pages 1-11.
Crossref
Songporn Oranratnachai, Sasivimol Rattanasiri, Anantaporn Pooprasert, Amarit Tansawet, Thanyanan Reungwetwattana, John Attia & Ammarin Thakkinstian. (2021) Efficacy of First Line Systemic Chemotherapy and Multikinase Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology 11.
Crossref
Xiaolong Tang, Amin Li, Chunmei Xie, Yinci Zhang, Xueke Liu, Yinghai Xie, Binquan Wu, Shuping Zhou, Xudong Huang, Yongfang Ma, Weiya Cao, Ruyue Xu, Jing Shen, Zhen Huo, Shuyu Cai, Yong Liang & Dong Ma. (2020) RETRACTED ARTICLE: The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway. Nanoscale Research Letters 15:1.
Crossref
Jingjing Liu, Xueni Liu, Jing Ma, Ke Li & Chao Xu. (2019) The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: A PRISMA-compliant meta-analysis. Bioscience Reports 39:11.
Crossref
Clemens Schotten, Lars P. Bechmann, Paul Manka, Jens Theysohn, Alexander Dechêne, Amr El Fouly, Francesco Barbato, Ursula Neumann, Sonia Radünz, Svenja Sydor, Dominik Heider, Marino Venerito, Ali Canbay, Guido Gerken, Ken Herrmann, Heiner Wedemeyer & Jan Best. (2019) NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization. Liver Cancer 8:6, pages 491-504.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.